Pozelimab-bbfg
Customize your policy alerts
Sign up for healthspring Policy RX501.182 alerts
Get alerted when Policy RX501.182 changes without checking for updates manually.
Monitor payer policy activity
HealthSpring coverage of pozelimab-bbfg (Veopoz) for adult and pediatric members age 1 year and older with CD55-deficient protein-losing enteropathy (CHAPLE disease), subject to specified genetic, laboratory, and symptom criteria.
No material clinical or coverage changes in this revision.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.